Literature DB >> 11878931

Vaccinia virus CrmE encodes a soluble and cell surface tumor necrosis factor receptor that contributes to virus virulence.

Patrick C Reading1, Anu Khanna, Geoffrey L Smith.   

Abstract

Poxviruses encode soluble cytokine receptors to interfere with host immune functions. Cells infected with vaccinia virus (VV) strains USSR, Lister, and Evans express soluble and cell surface tumor necrosis factor receptors (vTNFRs). We have characterized vTNFR activity in VV USSR and identified an open reading frame that encodes both soluble and cell surface activity, hereafter referred to as VV cytokine response modifier E (VV CrmE). Expression and characterization from recombinant VV and baculovirus showed VV CrmE to be an 18-kDa protein that bound human, mouse, and rat TNF-alpha, but not human LT alpha. VV CrmE inhibited the cytotoxic and apoptotic activities of human, but not mouse or rat, TNF in vitro. Nonetheless, in a murine intranasal model, USSR recombinants lacking CrmE were attenuated, demonstrating a role in vivo. Furthermore, expression of VV or cowpox virus vTNFRs from VV strain WR (which itself does not express a vTNFR) was shown to enhance virulence in the murine model.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11878931     DOI: 10.1006/viro.2001.1236

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  26 in total

Review 1.  Poxvirus immunomodulatory strategies: current perspectives.

Authors:  J B Johnston; Grant McFadden
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

2.  Out of the Reservoir: Phenotypic and Genotypic Characterization of a Novel Cowpox Virus Isolated from a Common Vole.

Authors:  Donata Hoffmann; Annika Franke; Maria Jenckel; Aistė Tamošiūnaitė; Julia Schluckebier; Harald Granzow; Bernd Hoffmann; Stefan Fischer; Rainer G Ulrich; Dirk Höper; Katja Goller; Nikolaus Osterrieder; Martin Beer
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

3.  Genome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipients.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; V Shane Pankratz; Iana H Haralambieva; Robert A Vierkant; Gregory A Poland
Journal:  Hum Genet       Date:  2012-05-19       Impact factor: 4.132

4.  Resistance to vaccinia virus is less dependent on TNF under conditions of heterologous immunity.

Authors:  Siwei Nie; Markus Cornberg; Liisa K Selin
Journal:  J Immunol       Date:  2009-10-21       Impact factor: 5.422

5.  Kinetics of serum cytokines after primary or repeat vaccination with the smallpox vaccine.

Authors:  Jeffrey I Cohen; Patricia Hohman; Rachael Fulton; Siu-Ping Turk; Jing Qin; Karen Thatcher; Ronald L Hornung
Journal:  J Infect Dis       Date:  2010-04-15       Impact factor: 5.226

6.  What a Difference a Gene Makes: Identification of Virulence Factors of Cowpox Virus.

Authors:  Aistė Tamošiūnaitė; Saskia Weber; Timo Schippers; Annika Franke; Zhiyong Xu; Maria Jenckel; Florian Pfaff; Donata Hoffmann; Maegan Newell; B Karsten Tischer; Martin Beer; Nikolaus Osterrieder
Journal:  J Virol       Date:  2020-01-06       Impact factor: 5.103

7.  Comparative Biochemical and Functional Analysis of Viral and Human Secreted Tumor Necrosis Factor (TNF) Decoy Receptors.

Authors:  Sergio M Pontejo; Ali Alejo; Antonio Alcami
Journal:  J Biol Chem       Date:  2015-05-04       Impact factor: 5.157

8.  Deletion of major nonessential genomic regions in the vaccinia virus Lister strain enhances attenuation without altering vaccine efficacy in mice.

Authors:  Julie Dimier; Audrey Ferrier-Rembert; Karine Pradeau-Aubreton; Matthias Hebben; Danièle Spehner; Anne-Laure Favier; Danielle Gratier; Daniel Garin; Jean-Marc Crance; Robert Drillien
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

9.  Epstein-Barr virus immediate-early protein BZLF1 inhibits tumor necrosis factor alpha-induced signaling and apoptosis by downregulating tumor necrosis factor receptor 1.

Authors:  Thomas E Morrison; Amy Mauser; Aloysius Klingelhutz; Shannon C Kenney
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

10.  The highly attenuated oncolytic recombinant vaccinia virus GLV-1h68: comparative genomic features and the contribution of F14.5L inactivation.

Authors:  Qian Zhang; Chunguang Liang; Yong A Yu; Nanhai Chen; Thomas Dandekar; Aladar A Szalay
Journal:  Mol Genet Genomics       Date:  2009-08-22       Impact factor: 3.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.